← Back to Search

Mepitel Film for Radiation Dermatitis in Breast Cancer Patients Post-Mastectomy

Ames, IA

Phase 3

Waitlist Available

Research Sponsored by Alliance for Clinical Trials in Oncology

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No active collagen vascular diseases (i.e. lupus erythematosus, scleroderma, dermatomyositis)

No current inflammatory breast cancer, or gross dermal involvement at initiation of radiotherapy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 months

Awards & highlights

No Placebo-Only Group

Pivotal Trial

Summary

This trial studies Mepitel Film for reducing radiation dermatitis in patients with breast cancer during radiation therapy after a mastectomy.

See full description

Who is the study for?

This trial is for breast cancer patients who've had a mastectomy and are scheduled for radiation therapy without active rashes, inflammatory breast cancer, or severe skin conditions. They shouldn't have had prior radiotherapy in the area, be allergic to adhesives, or be on cytotoxic chemotherapy. Participants must speak English and have a life expectancy over 2 years.Check my eligibility

What is being tested?

The study is testing Mepitel Film's effectiveness in reducing skin redness and peeling caused by radiation therapy in post-mastectomy breast cancer patients. It involves questionnaire administration and quality-of-life assessments to evaluate patient experiences.See study design

What are the potential side effects?

While not explicitly stated, potential side effects may include discomfort or an allergic reaction to the Mepitel Film dressing material used during radiation treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not have any active collagen vascular diseases like lupus.

show original

Select...

I do not have inflammatory breast cancer or visible skin involvement.

show original

Select...

I do not have any health conditions that would limit my life to less than 2 years.

show original

Select...

I have never had an organ or bone marrow transplant.

show original

Select...

I can speak and read English.

show original

Select...

I do not have an active rash or skin condition in the area to be treated.

show original

Select...

I am scheduled for standard photon radiation therapy.

show original

Select...

I am not on any chemotherapy, but I may be taking hormone therapy or HER2 treatments.

show original

Select...

My breast cancer has been confirmed and staged.

show original

Select...

I have not had radiation therapy on the area to be treated.

show original

Select...

I had a mastectomy recently, with or without reconstruction.

show original

Select...

I am fully active or can carry out light work.

show original

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Serially measured patient-completed modified Radiation Induced Skin Reaction Assessment Scale (mRISRAS) scores

Secondary study objectives

Centralized, blinded provider-completed modified Radiation Induced Skin Reaction Assessment Scale (mRISRAS) scores obtained from a blinded grading of the photographs taken at the end of radiation therapy

Serially measured combined patient- and provider-completed modified Radiation Induced Skin Reaction Assessment Scale (mRISRAS) scores

Serially measured non-blinded institutional provider-completed modified Radiation Induced Skin Reaction Assessment Scale (mRISRAS) scores